- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/00 - Drugs for disorders of the nervous system
Patent holdings for IPC class A61P 25/00
Total number of patents in this class: 18700
10-year publication summary
|
708
|
1006
|
1194
|
1285
|
1356
|
1440
|
1460
|
1292
|
1112
|
732
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7832 |
259 |
| The Regents of the University of California | 20690 |
200 |
| Takeda Pharmaceutical Company Limited | 2714 |
165 |
| Janssen Pharmaceutica N.V. | 3177 |
155 |
| Hoffmann-La Roche Inc. | 3773 |
146 |
| Centre National de La Recherche Scientifique | 10993 |
95 |
| H. Lundbeck A/S | 1231 |
95 |
| The Johns Hopkins University | 5874 |
87 |
| Glaxo Group Limited | 4376 |
82 |
| Pfizer Inc. | 3384 |
80 |
| Novartis AG | 10300 |
78 |
| Daiichi Sankyo Company, Limited | 1894 |
78 |
| Sage Therapeutics, Inc. | 309 |
77 |
| Boehringer Ingelheim International GmbH | 4501 |
73 |
| sanofi-aventis | 308 |
73 |
| Osaka University | 3269 |
62 |
| Bristol-myers Squibb Company | 4721 |
61 |
| Neurosearch A/S | 146 |
61 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3337 |
60 |
| Vanderbilt University | 2012 |
58 |
| Other owners | 16655 |